Founder & CEO
SH360 Medical Corporation (Sure Health 360)
Dr Daryl Joel C. Dumdum is the Founder and CEO of SH360 Medical Corporation, with a background in Family Medicine, preventive care and regenerative medicine. He leads an integrated healthcare ecosystem spanning clinical care, research, education, innovation and strategic health services, guided by a commitment to responsible medical advancement, evidence-based clinical judgment and patient-centred care.
Healthcare becomes truly consequential when innovation is measured not by how advanced it appears, but by how responsibly it changes a person’s life. Dr. Daryl Joel C. Dumdum, Founder and Chief Executive Officer of SH360 Medical Corporation, has built his career around that distinction, moving from Family Medicine and preventive care into regenerative medicine while keeping clinical judgment at the centre. As CEO, he brings clinical care, research, education, innovation, and strategic health services together under one healthcare ecosystem, with a vision shaped as much by personal loss as by scientific curiosity. His work reflects a broader belief that healthcare must evolve without losing its human foundation. In this conversation, TradeFlock Magazine explores the experiences, leadership principles and convictions shaping Daryl’s vision for a more connected and responsible future of medicine.
Two losses shaped the doctor I became. The first was my mother, whom I lost as a young boy in circumstances our family believed involved medical malpractice. Clinical protocols and medical terminology meant nothing to me then. I only understood that my mother went for medical care, something went terribly wrong and she never came home. The helplessness stayed with me for years and eventually became part of why I wanted to understand medicine.
Years later, I lost my father to a largely preventable disease. I was already a Family Medicine specialist, yet despite everything I had learned, I could not save him. His death forced me to ask why we wait for people to become seriously ill before becoming serious about their health.
The question drew me toward Regenerative Medicine, precision and translation, and eventually established Sure Health 360. My mother helped make me a doctor. My father made me question what kind of doctor I wanted to be.
One of the greatest misconceptions about regenerative medicine is that a physician’s job is simply to decide which stem cell, exosome or biological product to give. I believe the opposite. The most important decision is often deciding who should not receive a regenerative intervention.
Patients can arrive after exhausting conventional options, carrying years of neurological conditions, degenerative disorders, chronic pain or disability. Hearing the words “regenerative medicine” can mean something much more powerful to them. They hear hope, and hope creates an enormous ethical responsibility for the physician.
I have seen patients achieve meaningful improvements in function, mobility, pain and quality of life. I have also encountered patients whose disease had progressed beyond what current approaches could reasonably reverse. Protecting hope sometimes means saying, “I do not believe this treatment is appropriate for you,” even when someone is willing to pay for it.
Medicine must ask whether the science justifies an intervention or whether we are using it simply because the technology exists.
The human body does not recognise medical specialities. The heart does not operate independently from the kidneys, the immune system does not function separately from metabolism, and sleep, muscle, inflammation and mental wellbeing all influence health and recovery. As a physician, this shapes how I treat patients. As CEO of SH360, it also shapes how I think about building a healthcare organisation.
My foundation in Family Medicine has been invaluable because it taught me to look at the entire person before discussing an advanced intervention. That same principle has influenced how we bring different disciplines, clinical services, research, education and innovation together across SH360. I want to understand blood pressure, glucose control, insulin resistance, sleep, nutrition, muscle loss, physical activity, cardiovascular risk and psychological wellbeing before considering cellular therapies.
There is little sense in discussing sophisticated treatments while ignoring uncontrolled diabetes, smoking, severe obesity, hypertension, malnutrition, inactivity or poor sleep. Advanced biology cannot compensate indefinitely for an unhealthy biological environment.
I describe our approach as 360-degree medicine. Prevention comes first, evidence-based medicine remains foundational, and regenerative approaches become another tool when the evidence, regulation, patient selection and clinical circumstances support them.
Regenerative medicine has a credibility problem because legitimate science now exists alongside enormous commercial enthusiasm. A scientific paper, animal study, early clinical trial and approved therapy can all become “Scientists discovered a cure” after passing through social media. Patients need much clearer distinctions between what is established, what is emerging and what remains experimental.
Responsible innovation requires better evidence, standardised outcomes, registries, long-term follow-up, adverse-event reporting and intellectual honesty. Physicians should be able to say, “This is what we know. This is what we think. This is what we still do not know.”
Longevity needs the same discipline. The conversation should not revolve only around how long we live. Healthspan matters more, including physical capability, cognitive function, metabolic health, independence and meaningful relationships. Healthy ageing begins decades before old age, while some of the most powerful interventions remain remarkably simple.
Master the foundations before attempting to change the frontier. Young doctors may witness personalised cellular therapies, gene editing, engineered tissues, increasingly precise immunotherapies, AI-assisted medicine and entirely new approaches to ageing. Excitement is valuable, but excitement is not evidence and innovation does not automatically progress.
Excellent physicians need to understand physiology, pathology, pharmacology, scientific papers, statistics, clinical-trial design and conflicts of interest. They also need to learn how to listen to patients. Strong foundations make it possible to explore the frontier, question established assumptions and study emerging technologies without allowing technology to become more important than the patient.
I often ask myself one question. If the patient sitting in front of me were my mother, father or child, would I recommend exactly the same thing? The greatest physicians will be curious enough to explore what is possible and disciplined enough to demand evidence. When another human being places their life in our hands, their welfare must remain more important than our ambition.
“The more powerful our technology becomes, the greater our responsibility should be.”
Thank You For Subscribing
There was an error while trying to send your request. Please try again.